Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016; New Report Launched
Coagulation Factor XI – Pipeline Review, H1 2016; Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by Companies and remaining by the Universities/Institutes.
View full press release